SEC Form 4Coverage since May 22, 2026
$HCWB insider trading
Over the last 12 months, HCW Biologics insiders reported 6 buys totaling $530K and no sales across SEC Form 4 filings.
- Bought · 12m
- $530K 6 events
- Sold · 12m
- — 0 events
- Events · 12m
- 6 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $HCWB · 12Mvia TradingView
Top insiders · 12m
GARRETT SCOTT T—2× · $270K
Wong Hing CChief Executive Officer2× · $220K
Byam RebeccaChief Financial Officer1× · $20K
Flowers LeeSVP of Business Development1× · $20K
All insider trades
6 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Wong Hing CChief Executive Officer · O·D·10% | ▲ Buy | 23,210 | $2.58 | $60K | +22.6% | — |
| Jul 29, 2026 | Flowers LeeSVP of Business Development · O | ▲ Buy | 7,736 | $2.58 | $20K | +810.1% | — |
| Jul 29, 2026 | GARRETT SCOTT TD | ▲ Buy | 7,736 | $2.58 | $20K | +22.8% | indirect |
| May 22, 2026 | Wong Hing CChief Executive Officer · O·D·10% | ▲ Buy | 113,879 | $1.41 | $160K | +22.7% | — |
| May 22, 2026 | GARRETT SCOTT TD | ▲ Buy | 177,936 | $1.4 | $250K | +697.7% | indirect |
| May 22, 2026 | Byam RebeccaChief Financial Officer · O | ▲ Buy | 14,235 | $1.41 | $20K | +33.1% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $HCWB feed.